Dall’Olio, Lorenzo
Curti, Nico
Remondini, Daniel
Safi Harb, Yosef
Asselbergs, Folkert W.
Castellani, Gastone
Uh, Hae-Won
Funding for this research was provided by:
EU/EFPIA Innovative Medicines Initiative 2 (116074, 116074)
H2020 Marie Skłodowska-Curie Actions (721815, 721815)
Article History
Received: 8 May 2020
Accepted: 23 October 2020
First Online: 12 November 2020
Competing interests
: Y.S.H. is a shareholder at Happitech. The other authors declare that they have no competing interests.